Susquehanna International Group’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,700
Closed -$90.1K 13568
2025
Q3
$90.1K Sell
28,700
-23,300
-45% -$91.4K ﹤0.01% 11628
2025
Q2
$246K Buy
52,000
+28,700
+123% +$134K ﹤0.01% 10778
2025
Q1
$110K Buy
+23,300
New +$136K ﹤0.01% 11480
2023
Q2
Sell
-28,200
Closed -$147K 13084
2023
Q1
$147K Buy
28,200
+14,900
+112% +$107K ﹤0.01% 10930
2022
Q4
$98.7K Sell
13,300
-16,400
-55% -$148K ﹤0.01% 10972
2022
Q3
$372K Sell
29,700
-12,400
-29% -$148K ﹤0.01% 9256
2022
Q2
$323K Buy
+42,100
New +$353K ﹤0.01% 9386

Other funds holding SRTS

Susquehanna International Group's SRTS Position: Q1 2026 in Review

Susquehanna International Group sold out of Sensus Healthcare (SRTS) in Q1 2026, closing a stake of 47,680 shares — an estimated $212K sold.

Susquehanna International Group first reported a position in SRTS in Q1 2019 and held it in 14 quarters. The position peaked at $455K in Q1 2025. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Susquehanna International Group reported no remaining Sensus Healthcare position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 47,680 Sensus Healthcare shares in Q1 2026, an estimated $212K.
  • Susquehanna International Group first reported a position in Sensus Healthcare in Q1 2019 and held it in 14 quarters.
  • Susquehanna International Group's Sensus Healthcare position peaked at $455K in Q1 2025.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.